Find required training to obtain a buprenorphine waiver. SAMHSA offers tools, training, and technical assistance to practitioners in the fields of mental and substance use disorders. Find information on SAMHSA training and resources. SAMHSA tracks the number of DATA-waivered practitioners eligible to provide buprenorphine treatment of opioid use disorder (OUD) and program data. Find totals of waivered practitioners by licensure as well as by state. It is critical that all practitioner contact and practice information is current. It is recommended that practitioners review their information periodically and update as necessary to ensure its accuracy. Practitioners must understand and adhere to specific federal buprenorphine record keeping requirements. Every year, per 42 CFR 8.635, qualified practitioners approved to treat up to 275 patients must submit information about their practice to SAMHSA for purposes of monitoring regulatory compliance. The goal of the reporting requirement is to ensure that practitioners are providing buprenorphine treatment in compliance with the final rule Medication Assisted Treatment for Opioid Use Disorders (81 FR 44711). Learn more about buprenorphine.